
GC10770
Decernotinib(VX-509)
Also known as (2R)-2-methyl-2-[[2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]-N-(2,2,2-trifluoroethyl)butanamide
Decernotinib(VX-509) is a potent, orally active JAK3 inhibitor, with Kis of 2·5, 11, 13 and 11 nM for JAK3, JAK1, JAK2, and TYK2, respectively
ChemicalCAS944842-54-0MW392.38FormulaC18H19F3N6O
- CAS number
- 944842-54-0
- Molecular weight
- 392.38
- Formula
- C18H19F3N6O
- Solubility
- ≥ 16·95mg/mL in DMSO
- InChIKey
- ASUGUQWIHMTFJL-QGZVFWFLSA-N
- Catalogue number
- GC10770
- Brand
- GLPBIO
Computed properties PubChem CID 59422203 · XLogP 3.1 · TPSA 95.6 Ų · H-bond donors 3
- XLogP
- 3.1
- TPSA
- 95.6 Ų
- H-bond donors
- 3
- H-bond acceptors
- 8
- Rotatable bonds
- 6
- Heavy atoms
- 28
SMILES CC[C@](C)(C(=O)NCC(F)(F)F)NC1=NC(=NC=C1)C2=CNC3=C2C=CC=N3
Computed descriptors from PubChem (CID 59422203), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il